CA
Cormorant Asset Management, LP disclosed a 8.1% stake in DRUG
Cormorant Asset Management, LP reported owning 8.1% of Bright Minds Biosciences Inc. (DRUG) (800,000 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G